Position in TRVI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,935,368
-$1,840,981 QoQ
Shares Held
264,631
-51.1% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#63
of 218 holders
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Informed Momentum Co LLC holds $117,620,448 across 34 Biotechnology names. TRVI ranks #12 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
49,357 | $9,243,578 | |
| 2 | TVTX |
Travere Therapeutics, Inc.
|
117,987 | $6,702,841 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
26,152 | $6,401,225 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
19,498 | $6,163,122 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
16,227 | $6,031,089 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
24,544 | $5,914,367 | |
| 7 | CYTK |
Cytokinetics Inc
|
68,185 | $5,808,680 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
120,928 | $5,688,453 |
All Filings in TRVI
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,935,368 | 264,631 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $6,776,349 | 541,242 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,027,732 | 549,479 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,661,833 | 486,624 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,465,280 | 550,919 | Shares | Sole | 2025-05-13 | |
| 2022-09-30 | $89,631 | 58,202 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,048,812 | 373,243 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||